BioKey to Spin-Off and Distribute 15% Of Its Shares
ABVC BioPharma, Inc. announced a plan to separate BioKey (Cayman), Inc. through a spin-off and pro rata distribution of 15% of Subsidiary's ordinary shares to Parent shareholders. The move aims to enhance shareholder value by separating the two distinct businesses.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day